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Calcium’s role as nuanced modulator of cellular physiology in 
the brain
Hilaree N Frazier, Shaniya Maimaiti, Katy L Anderson, Lawrence D Brewer, John C Gant, 
Nada M Porter, and Olivier Thibault
UKMC, MS-313, Department of Pharmacology and Nutritional Sciences, University of Kentucky 
Medical Center, 800 Rose Street, Lexington, KY 40536
Abstract
Neuroscientists studying normal brain aging, spinal cord injury, Alzheimer’s disease (AD) and 
other neurodegenerative diseases have focused considerable effort on carefully characterizing 
intracellular perturbations in calcium dynamics or levels. At the cellular level, calcium is known 
for controlling life and death and orchestrating most events in between. For many years, 
intracellular calcium has been recognized as an essential ion associated with nearly all cellular 
functions from cell growth to degeneration. Often the emphasis is on the negative impact of 
calcium dysregulation and the typical worse-case-scenario leading inevitably to cell death. 
However, even high amplitude calcium transients, when executed acutely can alter neuronal 
communication and synaptic strength in positive ways, without necessarily killing neurons. Here, 
we focus on the evidence that calcium has a subtle and distinctive role in shaping and controlling 
synaptic events that underpin neuronal communication and that these subtle changes in aging or 
AD may contribute to cognitive decline. We emphasize that calcium imaging in dendritic 
components is ultimately necessary to directly test for the presence of age- or disease-associated 
alterations during periods of synaptic activation.
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1. Introduction
The role of calcium in neurodegenerative disorders has evolved significantly since early 
experiments showing hippocampal cell death in areas CA3 and CA1 in response to sustained 
synaptic activation of the perforant path in vivo [1]. These, and similar early experiments 
identified mechanisms of neuronal death reminiscent of calcium-induced necrosis, 
accompanied with blebbing of dendrites, retraction of processes, swelling of the soma and, 
ultimately, cellular death [2; 3; 4]. Framed in the context of a lengthy exposure to 
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glutamatergic neurotransmitters, these necrosis-associated events provided robust evidence 
that calcium could be a perpetuator of cell death. However, a combination of advanced 
reporter technologies and improved resolution in calcium imaging techniques have provided 
more recent evidence that calcium can be very subtle and localized to small cellular domains 
in response to subthreshold or suprathreshold transient synaptic depolarizations.
In the field of neuronal calcium dynamics, perhaps understandably, there appears to be a 
subjective preoccupation with the harmful effects of calcium dysregulation. However, a brief 
survey of the literature shows this is not well supported by the extent of the overall research 
in this area. Here we attempted to translate this idea in graphical form using data on 
published manuscripts across several fields. Examination of the literature between 1970 and 
2015 (Fig. 1) shows the number of published manuscripts linking “brain” and “calcium” to a 
variety of other neurological changes in brain physiology, and pathology over the 45-year 
span. As a proportion of the total number of published manuscripts in all fields of science, 
the number of published work on brain calcium and physiology increased nearly 10-fold 
between the years 1975 and 2000 (Fig 1A). It is interesting to note that whether looking at 
aging (Fig. 1B) or AD reports (Fig. 1C), physiological associations between brain and 
calcium represent the largest proportion of the overall scientific published work, while cell 
death, and pathology associated processes encompass a smaller body of work. We then 
determined what proportion of the manuscripts in the following categories: “calcium and 
brain” or “calcium and brain aging” or “calcium and brain and AD“, focused on either 
physiology, cell death of pathology. The data obtained every 5 years were then averaged 
across the last 30 years (Fig.1D). While scientific output steadily increased over that period 
(e.g., calcium and brain return 826 manuscripts in 1985, and 2032 manuscripts in 2015), the 
proportion of physiologically-related manuscripts within each of the categories has remained 
greater (~23 % to 55%, Fig 1D) compared to papers associating calcium in the brain with 
pathology or cell death (~3% to 20%). A caveat should be added that we did not attempt to 
identify repeat manuscripts in the dataset (i.e., papers studying both physiology and 
pathology in relationship to calcium in the brain), thus, the numbers we report may be 
slightly inflated. Nevertheless, together, these data suggest that more studies have been 
published on associations between calcium and its physiological consequences rather than 
on how calcium influences cell death or pathophysiology.
Here we briefly review how age- and neurodegeneration-related changes in oxidation/
inflammation and certain hormones influence calcium dysregulation and impact cellular 
physiology. We also discuss the importance of focusing on the more subtle and localized 
calcium microdomains in neurons to better elucidate the impact of changes in calcium 
signaling in aging or in disease.
2. Calcium dysregulation in Alzheimer’s disease (AD) and AD models
Early studies by several pioneering groups identified cellular calcium dysregulation as a 
major factor underlying functional alterations in aging tissues. These observations 
contributed to the formulation of the calcium hypothesis of brain aging and AD [5; 6]. This 
work was followed by studies in human cortical cells showing that the β-amyloid peptide 
increases calcium levels at rest and in response to excitatory neurotransmitter release, 
Frazier et al. Page 2
Biochem Biophys Res Commun. Author manuscript; available in PMC 2018 February 19.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
resulting in compromised neuronal cell health [7]. Later studies in neurons harboring 
presenilin-1 (PS-1) mutations, a key player in Aβ formation, helped identify several 
endoplasmic reticulum (ER) calcium handling proteins as targets of the genetic mutation [8]. 
Even human fibroblast and lymphoblasts display robust evidence of calcium dysregulation 
in AD [9; 10; 11], suggesting the dysregulation may be “system-wide” rather than just CNS-
centered. Whether calcium dysregulation is a crucial initiator of the neuronal pathology, or a 
downstream event has been an open-ended question. Some studies have placed abnormal 
Ca2+ elevations downstream of PS-1 mutations [12; 13; 14]. On the other hand, ryanodine 
receptors and IP3 receptors have been identified as perpetrators of calcium dysregulation 
[15; 16; 17; 18; 19; 20] and reducing IP3R expression in 3×Tg mice attenuates Ca2+ 
signaling, Aβ production and Tau hyperphosphorylation [20]. PS1 and PS2 mutations have 
also been found to directly target ER function, reducing ER calcium leaks, and overloading 
the ER with excess calcium [21; 22; 23]. Loss-of-function PS1 mutations are also associated 
with disturbed calcium-dependent lysosomal and autophagic pathways [24; 25]. 
Interestingly, recent studies in animal models of AD using multiphoton calcium imaging 
techniques demonstrate that calcium overload may not be generalized to all neurons and 
could be dependent on proximity to a Aβ plaque [26; 27]; however, another study finds no 
association between distance from a plaque and neuronal calcium dysregulation [28]. In 
addition, neurofibrillary tangles do not appear to alter calcium levels or cellular excitability 
in the visual and somatosensory cortex [29], nor do they appear to alter calcium homeostasis 
in the cortex of animals displaying significant synapse loss [30].
Our understanding of the relationship between calcium dysregulation and AD in the brain 
still lacks clarity, and calcium dysregulation may also act upstream of AD pathology, 
whereby elevations in Ca2+ can increase production of oligomeric Aβ peptides [31]. As 
such, stabilizing ER calcium with dantrolene, a ryanodine receptor antagonist, restores 
normal synaptic function and plasticity and reduces amyloid load in the brains of 3×Tg AD 
mice [32] and knock-in FAD mice [33].
3. Oxidative stress, inflammation, and calcium
Calcium dysregulation tied to oxidative stress or inflammation in neuronal cells can have 
deleterious and long-lasting consequences resulting in calcium overload which may increase 
neuronal vulnerability under pathological conditions including AD [13; 19; 34; 35; 36]. 
Indeed, sustained NMDA receptor activation or even reduced NMDA receptor inactivation 
can increase calcium elevations (immediate or delayed) which in turn, can produce reactive 
oxygen species (ROS) as a result of increased mitochondrial energy demands [37]. Still, it is 
not clear that the increase in ROS seen around the time of neuronal cell death with calcium 
overload is actually the cause of death or the consequence of the depolarized mitochondria 
[37].
ROS production in response to Aβ peptides or other challenges in the brain [38; 39] is well 
known to alter protein function [40; 41], and recently has also been shown to directly alter 
calcium channels [42; 43]. Still, the threshold (if there is one) to induce these devastating 
signaling pathways and the relationship to Ca2+ levels in vivo has been as difficult to 
identify as the targets of the oxidative stressors in the brain [44]. The poor clinical 
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therapeutic translation seen in AD patients taking anti-oxidative therapies may be due to the 
fact that the precise targets are still unknown [45].
Brain inflammation, mediated by numerous cytokines (TNF-alpha, AIF, JNK) is common 
across brain aging and AD studies [46; 47; 48; 49] and has been linked to calcium 
dysregulation. This calcium dysregulation, in turn has been shown to have consequences for 
synaptic plasticity [50; 51]. Calcium dysregulation alters the balance between LTP and LTD 
presumably through changes in the activation of select phosphatases and kinases [52; 53; 54; 
55; 56]. However, this relationship has never been tested in vivo or with sufficient spatial or 
temporal resolution to address calcium dynamics in microdomains near postsynaptic 
densities at the exact sites of synaptic communication. Given the complex structure of 
postsynaptic densities in dendritic spines which includes ion channels, anchoring proteins, 
kinases and phosphatases [57; 58; 59; 60; 61], this is a particularly important challenge that 
can only be surmounted with higher resolution microscopy that allows for measures of very 
controlled calcium rises during synaptic activation. Studies using tissue homogenates may 
be missing the impact of inflammation on calcium microdomains and the resulting synaptic 
processes.
At least one aspect of the association between oxidant/ inflammatory stressors and calcium 
dysregulation that has not received enough attention is whether different thresholds of 
dysregulation result in select activation of downstream pathways and/or different outcomes 
[7; 62; 63]. For example, it is not clear whether several repeated calcium events of smaller 
amplitudes (i.e., ministrokes) are as impactful as a single, large amplitude event (i.e., TBI, 
stroke). Also unclear, is whether the sensitivity of millisecond calcium cellular events to 
oxidant/inflammatory stressors changes across the lifespan.
4. The impact of disappearing hormones in the brain of aged animals may 
alter calcium homeostasis
While oxidative stress and inflammatory processes appear able to hasten calcium 
dysregulation with age, several endogenous steroid hormones including vitamin D, estrogen 
and insulin seem capable of redressing this dysregulation. We have shown that both vitamin 
D and estrogen alter L-VGCC activity and calcium-dependent processes. Vitamin D (1,25 
dihydroxvitamin D3) reduces L-VGCC currents probably due to reductions in both Cav1.2 
and Cav1.3 expression in primary hippocampal cultures [64]. This reduction in current 
activity was also found in CA1 hippocampal neurons and was correlated with an age-related 
reduction in the slow afterhyperpolarization (sAHP) which would affect neuronal 
excitability [65]. Further, long-term treatment (6 months) of rats beginning at mid-age (12 
months) with high vitamin D (10,000 IU cholecalciferol/ Kg rodent diet) showed improved 
spatial memory performance on the Morris water maze challenge. Thus, it appears that 
interfering with calcium homeostasis through pathways that are capable of increasing 
vitamin D receptor activation in the brain, may be a therapeutically meaningful strategy to 
preserve cognitive function in age and perhaps AD.
Another hormone, estradiol, has also been shown to modulate L-VGCC expression and 
activity in hippocampal neurons and in GnRH related cells [66; 67]. Interestingly, in both of 
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these cell types estradiol decreased Cav1.3 expression but not Cav1.2. In addition to 
affecting the expression of the L-VGCC subunit estradiol also modulates L-VGCC activity 
via a rapid mechanism that results in an increase in calcium influx through L-VGCCs in 
neurons and other cell lines [68; 69; 70]. This rapid pathway was proposed to be part of a 
neuroprotective pathway; whether it also functions to regulate physiological processes such 
as the sAHP is unknown. Nevertheless, the genomic mechanism appears to reduce L-VGCC 
activity but the rapid mechanism increases L-VGCC activity. This suggests the possibility 
that L-VGCC channel expression and calcium influx are dynamically regulated by estradiol, 
and as we and others have previously shown, can be altered in aging [66; 71].
Another recently identified hormone modulator of L-VGCC function in the brain is insulin. 
While investigating new mechanisms by which certain antidiabetic compounds can reduce 
calcium channel function and the AHP in hippocampal cells [72; 73], we also recently 
uncovered the acute and significant actions of insulin on the sAHP [74; 75]. By causing a 
significant reduction in the AHP, we predict insulin may be able to enhance cellular 
excitability in aging and offset cognitive decline. Indeed, several clinical studies have 
provided robust evidence that increasing brain insulin availability through intranasal delivery 
of the hormone is able to enhance recall in young subjects [76; 77] or MCI patients [78; 79; 
80]. Similarly, we have shown beneficial effects of intranasal insulin on memory recall in 
aged animals in the Morris water maze [74]. Surprisingly, both young healthy subjects and 
AD patients appear to benefit equally from intranasal insulin. At least in the case of AD, the 
intranasal administration is presumed to compensate for the reduced insulin signaling. 
Collectively, these results also suggest insulin signaling may be working differently in young 
vs aged brains. Irrespective, this work lends further support to continue therapeutic efforts 
attempting to maintain insulin signaling in the brain of the elderly population in order to 
offset cognitive decline with age or with AD.
In light of these studies, it is tempting to speculate that perhaps vitamin D, estrogen or 
insulin signaling are all compromised in the aged brain which may contribute to the 
development of dementia, and that increasing the availability of receptors for these 
hormones, or the levels of these hormones in the brain could combat cognitive decline in 
aging. Further, while it would seem that redressing calcium dyshomeostasis may be a pivotal 
approach to facilitate successful brain aging. However, more direct tests of this hypothesis 
are required, and investigating how these hormones regulate Ca2+ pathways will provide a 
framework on which to build new pharmacological approaches to combat cognitive decline 
in aging.
5. Cellular calcium transients have a dendritic origin
Nearly 20 years ago, imaging and electrophysiological approaches were used to derive new 
information on the complexity of dendritic actions and how neuronal output could be 
modified by key ion channels along the dendritic tree [81; 82; 83]. These findings 
culminated in the identification of different calcium sources along dendrites, main apical 
arbors, spines and shafts [84; 85; 86; 87; 88; 89]. The dendrite is the site for synaptic inputs 
where integration of signals from different areas of the brain occurs. As a result of action 
potential firing and the subsequent neurotransmitter release, small, albeit significant calcium 
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changes are seen in the dendrite and more specifically, the spines of neurons. There, the 
more subtle role of calcium in controlling encoding and dendritic excitability through local 
calcium transients is now becoming clear, and includes measures in behaving animals [90; 
91; 92; 93; 94; 95; 96]. In field CA1, primary hippocampal neurons are able to integrate 
signals coming from distal inputs from the entorhinal cortex, and more proximal inputs 
emitting from area CA3. At least part of this integration is mediated by newly identified 
dendritic calcium plateau potentials in vivo [97]. These short-lived dendritic calcium 
transients can help drive complex spike output in the main pyramidal neurons of the 
hippocampus by inactivating sodium channels, enhancing LTP [98] and thereby enhancing 
firing from coincident inputs in different areas of the brain. This complexity is only 
beginning to be elucidated in the dendrites of young or adult animals and this level of spatial 
and temporal resolution has not yet been achieved in animal models of aging or AD.
With the exception of a few additional studies, very little is known about dendritic calcium 
transients, their spatial and temporal integration, or about the presence and role of back 
propagating action potentials in apical dendrites in models of aging [99; 100]. Furthermore, 
these studies did not address changes in cellular cytoarchitecture/ morphology with age, its 
potential impact on physiology, nor did they study the impact of age-related changes in 
calcium sources on synaptic plasticity or activation. However, more progress along these 
lines has been made in animal models of AD. Using genetically-encoded calcium indicators 
to monitor calcium in spines of cultured neurons from mutant presenilin mice (M146V), 
recent evidence shows the presence of alterations in stromal interaction molecule 2 function 
(STIM2; a key regulator of store-operated calcium entry) [101; 102]. In these studies, the 
authors suggest that the loss of mushroom spines is mediated by the loss of the stabilizing 
effect of STIM2 on spines, and perhaps occurs in response to elevations in ER calcium 
levels during aging or in AD [14; 54; 103]. Such studies are helping to identify new 
pharmaceutical targets and are highlighting new areas of focus in neuroscience.
Work using calcium imaging tools to focus on downstream consequences of calcium 
overload in AD models has helped shift the attention away from calcium-mediated cell 
death, and instead emphasize calcium-mediated changes in dendritic morphology, cellular 
excitability, network activity and plasticity. The first direct in vivo evidence showing that 
elevated Ca2+ in cortical dendrites is dependent on the presence of Aβ plaque deposition was 
recently identified in an AD animal model. Somewhat surprisingly, it was not the presenilin 
mutation, but rather, the APP mutation which was found to be associated with calcium 
dysregulation in aged mice [27]. Further, in these APP mutants (17–20 months old), 
proximity to the plaque was shown to heighten Ca2+ dysregulation. In another in vivo study 
using double transgenic mice, imaging from hippocampal CA1 neuronal somata also 
provided evidence of Ca2+ overload, but at much earlier ages (1–2 months) and prior to 
plaque deposition. However, a role for soluble amyloid still exists as calcium transients and 
hippocampal excitability were elevated upon application of Aβ dimmers [26]. In both 
studies, thus it appears that some form of amyloid β may be responsible for inducing 
neuronal calcium dysregulation.
Greater spatial and temporal resolutions are currently being implemented in the study of 
neuroscience following the discovery of genetically-encoded calcium indicators [104; 105; 
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106]. These indicators have the advantage of being fast reporters which can be targeted to 
specific cellular compartments like the ER and the mitochondria [107; 108]. Studies 
investigating changes in calcium homeostasis using large arrays of cells are also now 
providing new in vivo results, but only in a limited number of studies in AD models [27; 29; 
109]. High resolution in vivo calcium imaging using pulsed lasers capable of generating 
longer wavelengths will provide important information along these lines.
6. New (and old) intricacies of calcium dysregulation with aging
Calcium is not always increased in aging and or in AD. Our lab has published evidence of 
reduced L-type Ca2+ currents in the aged APP/PS1 mouse [110]. Years ago, Lamour’s lab 
showed that calcium dysregulation did not translate well across different strains of rats 
[111]. Similarly, the Griffith lab also has reported that depending on L-type calcium channel 
subunits present, increases in L-type currents are not always seen with aging in basal 
forebrain neurons [112], and are often met with significant increases in calcium buffering 
capacity [113; 114; 115]. Recently, it was also shown that while more calcium enters the 
plasma membrane of an aged CA1 pyramidal neuron [100; 116], a corresponding increase in 
buffering balances this influx up to a point where calcium overload occurs [100]. Of interest, 
in a study of normal brain aging, we have identified that aged CA1 pyramidal neurons which 
typically display larger Ca2+-dependent afterhyperpolarizations when triggered 
postsynaptically, show significantly reduced hyperpolarization (e.g., enhanced 
hyperexcitability) compared to young animals, when stimulated synaptically across 
physiologically relevant frequencies (3–50 Hz) [117]. It is not yet clear that this form of 
hyperpolarization in the hippocampus with age during synaptic activity is dependent on 
calcium. It would be surprising if it were not, as stimulation at 7 Hz produces greater 
calcium in the soma [118] and dendrites [99; 100] in the aged animal. Given the importance 
of synaptic communication, stimulation protocols that approximate physiological patterns of 
activity may need to be studied further with aging and in AD-related neurodegeneration.
7. Overall
That changes in intracellular calcium levels occur with age and in Alzheimer’s type 
dementia or in other neurodegenerative conditions is not new. As we have known for some 
time, calcium can be a sophisticated orchestrator of fine moment-by-moment events, or a 
deadly hammer that can overload mitochondria and other calcium buffering systems. 
Currently, there is greater appreciation for how calcium is able to shape synaptic events that 
underpin neuronal communication. However, in aging and AD, it is unclear the extent to 
which dendritic Ca2+ sources are modified. Clearly, associations between an animal’s 
behavioral phenotype, electrophysiological characterization across multiple hippocampal 
subfields and regions (i.e., dorsal vs. ventral), network activity and sensitivity to hormones, 
all need further investigation to understand how calcium sensitive targets are modified in the 
context of aging. Perhaps insights from these types of studies will allow us to view calcium 
dysregulation in aging and AD as more than just a destructive force, but instead, allow us to 
pave the way for novel therapeutic approaches that focus on these more nuanced changes 
and their effects on neuronal physiology.
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• Dysregulated calcium is not only associated with cell death in aging or AD
• Improved resolution and reporter strategies need implementation in aging 
research
• Dendritic calcium imaging will provide insights into mechanisms of brain 
aging
• Hormonal influence over calcium regulation may be a promising therapeutic 
approach
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Figure 1. 
Survey of the literature relating to calcium dysregulation in the brain. A PubMed search was 
performed with EndNote using the terms “calcium” and “brain” (A) or “calcium” and 
“brain” and “aging” (B), or “calcium” and “brain” and “Alzheimer’s disease” (C). The 
number of papers containing the combined keywords and an association with “cell death”, 
“physiology”, or “pathology” was obtained once every five years between the years 1970 
and 2015 and was normalized to the total number of scientific publications that year. We 
then restricted the search to the past 30 years and collapsed the data across years and used 
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the same search strategy. This time, we normalized the number of papers in cell death, 
physiology or pathology to the total number of papers within “calcium” and “brain” or 
“calcium” and “brain” and “aging”, or “calcium” and “brain” and “Alzheimer’s disease” is 
shown in (D). It is clear that a greater proportion of the literature focusing on calcium in the 
brain contains a majority of the work centered on physiological outcomes.
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